Tectonic Therapeutic
TECX
51 hedge funds and large institutions have $434M invested in Tectonic Therapeutic in 2018 Q2 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
5.44% more ownership
Funds ownership: 0% → 5.44% (+5.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CV
Clarus Ventures
Cambridge,
Massachusetts
|
+$89.1M |
| 2 |
SHI
SV Health Investors
Boston,
Massachusetts
|
+$82.2M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$53.9M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$45.3M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$27.9M |
Top Sellers
TECX Hedge Fund Activity: Q2 2018 in Review
51 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q2 2018, worth a combined $434M.
Buyers outnumbered sellers: 51 funds opened new TECX positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Clarus Ventures, opening a new position worth an estimated $89.1M.
- 51 institutional investors held Tectonic Therapeutic (TECX) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $434M of Tectonic Therapeutic stock for Q2 2018.
- 51 funds opened new Tectonic Therapeutic positions in Q2 2018 and 0 closed out, a net change of +51 holders.
- The largest Tectonic Therapeutic buyer in Q2 2018 was Clarus Ventures, an estimated $89.1M added.
Based on aggregated 13F filings for Q2 2018.